ATE317451T1 - Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs - Google Patents

Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs

Info

Publication number
ATE317451T1
ATE317451T1 AT99924210T AT99924210T ATE317451T1 AT E317451 T1 ATE317451 T1 AT E317451T1 AT 99924210 T AT99924210 T AT 99924210T AT 99924210 T AT99924210 T AT 99924210T AT E317451 T1 ATE317451 T1 AT E317451T1
Authority
AT
Austria
Prior art keywords
colon cancer
diagnosis
classification
detection
staging
Prior art date
Application number
AT99924210T
Other languages
English (en)
Inventor
Roberto A Macina
Fei Yang
Yongming Sun
Original Assignee
Diadexus Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diadexus Inc filed Critical Diadexus Inc
Application granted granted Critical
Publication of ATE317451T1 publication Critical patent/ATE317451T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT99924210T 1998-05-21 1999-05-12 Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs ATE317451T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8626698P 1998-05-21 1998-05-21

Publications (1)

Publication Number Publication Date
ATE317451T1 true ATE317451T1 (de) 2006-02-15

Family

ID=22197408

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924210T ATE317451T1 (de) 1998-05-21 1999-05-12 Verfahren zur diagnose, erkennung, und einstufung von dickdarmkrebs

Country Status (6)

Country Link
EP (1) EP1080227B1 (de)
JP (1) JP3538381B2 (de)
AT (1) ATE317451T1 (de)
CA (1) CA2328128A1 (de)
DE (1) DE69929785T2 (de)
WO (1) WO1999060161A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858386B1 (en) 1998-05-21 2005-02-22 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
US6949339B1 (en) 1998-05-21 2005-09-27 Diadexus, Inc. Method of diagnosing, monitoring, and staging colon cancer
US6623923B1 (en) 1998-12-23 2003-09-23 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
ATE413466T1 (de) * 1998-09-02 2008-11-15 Diadexus Inc Verfahren zur diagnose, bewertung sowie bilddarstellung verschiedener krebserkrankungen
WO2000028031A2 (en) 1998-11-10 2000-05-18 Emory University Mitogenic regulators
US6284241B1 (en) 1998-12-23 2001-09-04 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
CA2356987A1 (en) * 1998-12-23 2000-06-29 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
CA2366778C (en) 1999-04-09 2008-07-22 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
US20020004206A1 (en) * 1999-04-09 2002-01-10 Berger Barry M. Methods of screening for disease
CA2396036A1 (en) * 1999-12-30 2001-07-12 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
CA2411278A1 (en) * 2000-06-09 2001-12-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
WO2002000939A2 (en) * 2000-06-28 2002-01-03 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating colon cancer
EP1313875A2 (de) * 2000-07-17 2003-05-28 Diadexus, Inc. Verfahren zur diagnose, zum überwachen, einstufen, abbilden und behandeln von colonkrebs
AU2001294999A1 (en) * 2000-08-07 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
DE10211088A1 (de) * 2002-03-13 2003-09-25 Ugur Sahin Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US7312197B2 (en) 2003-02-24 2007-12-25 University Of Maryland, Baltimore Method of modifying glucose activity using polypeptides selectively expressed in fat tissue
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US8058014B2 (en) 2006-09-29 2011-11-15 University Of Maryland, Baltimore Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733748A (en) * 1995-06-06 1998-03-31 Human Genome Sciences, Inc. Colon specific genes and proteins
WO1997042506A1 (en) * 1996-05-03 1997-11-13 Thomas Jefferson University Methods of and kits and compositions for diagnosing colorectal tumors and metastasis thereof
CA2285039A1 (en) * 1997-03-31 1998-10-08 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
JP2001522238A (ja) 1997-03-31 2001-11-13 アボツト・ラボラトリーズ 胃腸管の疾患の検出に有用な試薬および方法

Also Published As

Publication number Publication date
DE69929785T2 (de) 2006-07-20
JP3538381B2 (ja) 2004-06-14
WO1999060161A1 (en) 1999-11-25
CA2328128A1 (en) 1999-11-25
EP1080227A4 (de) 2002-09-18
EP1080227B1 (de) 2006-02-08
DE69929785D1 (de) 2006-04-20
EP1080227A1 (de) 2001-03-07
JP2002515591A (ja) 2002-05-28

Similar Documents

Publication Publication Date Title
DE69929785D1 (de) Verfahren zur Diagnose, Erkennung, und Einstufung von Dickdarmkrebs
DK1109937T3 (da) Fremgangsmåde til diagnosticering , monitorering, stadiebestemmelse og billeddiagnostisk undersögelse for forskellige cancere
DE69938662D1 (de) Spurendetektion von analyten mit hilfe artifizieller olfaktometrie
DE69938187D1 (de) Ykl-40 als marker und indikator zur prognose von krebs und detektion von infektionen
DE69939486D1 (de) Verfahren und vorrichtung für querflussassay
ATE337413T1 (de) Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen
ATE337011T1 (de) Modifizierte psma-liganden und deren verwendung
ATE515575T1 (de) Verfahren und sonden für den nachweis von krebs
WO2004060302A3 (en) Methods and compositions for the diagnosis, prognosis, and treatment of cancer
DE69940465D1 (de) Verfahren zum nachweis und hemmung der angiogenese
WO2004021008A3 (en) Methods for detecting breast and ovarian cancer
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE293704T1 (de) Methode und zusammensetzungen für die diagnose von extra-esophagem reflux
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
DE60036935D1 (de) Diagnostisches Verfahren für Eierstock- und Endometriumtumore basierend auf dem Nachweis des L1-Adhäsionsmoleküls
ATE347698T1 (de) Verfahren zum nachweis von alzheimer-krankheit
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
EP0774970A4 (de) Verfahren zur verwendung von hyaluronsäure zur detektion, lokalisation und diagnose von tumoren
ATE327766T1 (de) Verfahren zur diagnose, feststellung, einstufung, darstellung sowie behandlung gynäkologischer krebserkrankungen
ATE424562T1 (de) Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern
WO2002006515A3 (en) Method of diagnosing, monitoring, staging, imaging and treating colon cancer
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE442456T1 (de) Verfahren zur bestimmung von zirkulierender dns in plasma und zum nachweis von krebs
ATE423462T1 (de) Verfahren zur diagnose von prostatakrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties